Skip to Content
Chinese Medicine Regulatory Office
Site Menu
Home
>
What's New
>
Chinese medicine development in the Guangdong-Hong Kong-Macao Greater Bay Area
>
Chinese Medicines
Chinese Medicines
S for Health meets Guangdong Provincial Medical Products Administration delegation (with photos) (27 March 2023)
Health Bureau and Department of Health meet National Medical Products Administration delegation (with photos) (13 February 2023)
Forum on Drug Evaluation and Inspection affairs in the Guangdong-Hong Kong-Macao Greater Bay Area
(9 November 2022)
The Department of General Affairs of the National Medical Products Administration Issued the "Implementation Plan for Supporting Hong Kong and Macau Drug Marketing Authorization Holders to Produce Drugs in 9 Mainland Cities of the Greater Bay Area" (23 June 2022)
Documents required in applying for registration of locally manufactured pCms for export only(27 May 2022)
FHB welcomes approval of first batch of products for sale in Mainland under streamlined procedures for HK registered traditional pCms for external use to be registered in GBA
(31 December 2021)
Streamlining approval procedures for HK registered traditional pCms for external use to be registered in GBA
(29 September 2021)